Victoria Heinrich, MD, PhD
she/her/hers
Hospital ResidentCards
About
Research
Publications
2023
Meta-omics profiling of the gut-lung axis illuminates metabolic networks and host-microbial interactions associated with elevated lung elastance in a murine model of obese allergic asthma
Heinrich V, Uvalle C, Manni M, Li K, Mullett S, Donepudi S, Clader J, Fitch A, Ellgass M, Cechova V, Qin S, Holguin F, Freeman B, Methé B, Morris A, Gelhaus S. Meta-omics profiling of the gut-lung axis illuminates metabolic networks and host-microbial interactions associated with elevated lung elastance in a murine model of obese allergic asthma. Frontiers In Microbiomes 2023, 2: 1153691. PMID: 37293566, PMCID: PMC10249466, DOI: 10.3389/frmbi.2023.1153691.Peer-Reviewed Original Research
2022
Evolved resistance to a novel cationic peptide antibiotic requires high mutation supply
Santos-Lopez A, Fritz M, Lombardo J, Burr A, Heinrich V, Marshall C, Cooper V. Evolved resistance to a novel cationic peptide antibiotic requires high mutation supply. Evolution Medicine And Public Health 2022, 10: 266-276. PMID: 35712084, PMCID: PMC9198447, DOI: 10.1093/emph/eoac022.Peer-Reviewed Original Research
2021
Nitroalkene fatty acids modulate bile acid metabolism and lung function in obese asthma
Manni M, Heinrich V, Buchan G, O’Brien J, Uvalle C, Cechova V, Koudelka A, Ukani D, Rawas-Qalaji M, Oury T, Hart R, Ellgass M, Mullett S, Fajt M, Wenzel S, Holguin F, Freeman B, Wendell S. Nitroalkene fatty acids modulate bile acid metabolism and lung function in obese asthma. Scientific Reports 2021, 11: 17788. PMID: 34493738, PMCID: PMC8423735, DOI: 10.1038/s41598-021-96471-9.Peer-Reviewed Original ResearchAdolescentAdultAnimalsAnti-Asthmatic AgentsAntigens, DermatophagoidesAsthmaBile Acids and SaltsDiet, High-FatDrug Evaluation, PreclinicalFatty AcidsFemaleForced Expiratory VolumeGlycocholic AcidHumansLiverLungMaleMiceMice, Inbred C57BLMiddle AgedNitro CompoundsObesityOleic AcidsRespiratory HypersensitivityThinnessUrsodeoxycholic AcidVital CapacityYoung Adult
2017
Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase
Hurley K, Santos T, Fensterwald M, Rajendran M, Moore J, Balmond E, Blahnik B, Faulkner K, Foss M, Heinrich V, Lammers M, Moore L, Reynolds G, Shearn-Nance G, Stearns B, Yao Z, Shaw J, Weibel D. Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase. RSC Medicinal Chemistry 2017, 8: 942-951. PMID: 30034678, PMCID: PMC6051542, DOI: 10.1039/c7md00012j.Peer-Reviewed Original Research
2015
Membrane-Targeting DCAP Analogues with Broad-Spectrum Antibiotic Activity against Pathogenic Bacteria
Hurley K, Heinrich V, Hershfield J, Demons S, Weibel D. Membrane-Targeting DCAP Analogues with Broad-Spectrum Antibiotic Activity against Pathogenic Bacteria. ACS Medicinal Chemistry Letters 2015, 6: 466-471. PMID: 25941556, PMCID: PMC4416440, DOI: 10.1021/acsmedchemlett.5b00024.Peer-Reviewed Original Research